Who Can Administer Allergy Shots? Training, Competency & Emergency Readiness

AAAAI requires that all personnel administering allergen immunotherapy be trained in recognizing and treating systemic reactions, including anaphylaxis. The training covers five domains: subcutaneous injection technique with aseptic standards, pre-injection screening including patient verification and contraindication assessment, anaphylaxis recognition using WAO grading criteria, emergency epinephrine administration (intramuscular to the lateral thigh), and documentation requirements. This training is typically delivered through on-the-job supervised practice in the allergy setting, supplemented by AAAAI and ACAAI continuing education resources. Annual competency re-verification is recommended. BLS certification is generally required as a baseline for all clinical staff in settings that administer SCIT. New staff should complete 10-20 supervised injection sessions before independent practice.

An anaphylaxis mock drill is a simulated emergency response exercise where a trainer presents a realistic anaphylaxis scenario — a patient 10 minutes after injection who begins showing urticaria and throat tightness — and staff must respond as they would in a real emergency. The drill tests recognition time (how quickly the reaction is identified and graded), epinephrine administration technique (correct drug, correct dose, correct site, correct speed), team communication (who calls 911, who manages airway, who documents), and positioning. AAAAI recommends at least annual mock drills for all allergy practice staff who participate in injection administration. Drills reveal team coordination gaps that individual competency checks miss. Reviewing the drill together afterward with constructive feedback is a high-yield educational intervention for improving real-world emergency response readiness.

Pharmacists are trained in general injection technique — they routinely administer vaccines and some injectable medications. However, pharmacists are not trained in allergen immunotherapy-specific competencies: extract formulation and handling, allergen-specific dose escalation protocols, pre-injection allergy screening, or managing systemic allergic reactions in the context of immunotherapy. The pharmacist's scope of practice in the United States does not include allergen immunotherapy administration, regardless of general injection competency. Compounding pharmacies may prepare allergen extracts to an allergist's specifications, but the compounding role is entirely distinct from administration. There is also a third model the question often overlooks: supervised at-home self-administration. With Curex, a board-certified allergist prescribes a personalized SCIT serum and the eligible maintenance patient gives their own weekly shot at home — the first injection and every dose change supervised live over Zoom by the prescribing allergist, with a prescribed epinephrine auto-injector confirmed on hand. The qualification standard does not disappear; it is met by the supervising allergist rather than by an in-office injector.

New nurses should not administer allergy shots independently before completing a supervised training period. AAAAI safety recommendations and standard clinical practice suggest 10-20 supervised injection sessions before independent administration. During this period, an experienced immunotherapy nurse observes all injections, pre-injection screening, and post-injection monitoring to verify competency across all required domains. The supervised sessions allow the new nurse to develop consistent injection technique, become familiar with the practice's specific vial system and dose escalation protocols, and practice the pre-injection screening conversation. Emergency response — anaphylaxis recognition and epinephrine administration — should be trained through simulation or mock drill in addition to supervised observation, since actual anaphylaxis events may not occur during a new nurse's training window.

AAAAI recommends annual competency verification for all staff administering allergen immunotherapy. Annual re-verification should include: supervised demonstration of subcutaneous injection technique, review of pre-injection screening protocol application, anaphylaxis recognition assessment using case vignettes or mock drill, correct epinephrine administration technique (drug selection, dosing, IM site), and documentation accuracy review. BLS certification is typically required to be current (2-year renewal). Some practices conduct quarterly injection quality audits (reviewing logs for documentation completeness) in addition to annual competency verification. State boards may impose additional continuing education requirements for specific credential types — verify your state's current requirements for RNs, LPNs, MAs, or PAs administering medications by injection.

There is no mandatory individual ACAAI certification required for nursing or MA staff to administer allergy shots. The ACAAI and AAAAI both offer continuing education resources, practice assessment tools, and training curricula for allergy practices — but completion is not a regulatory prerequisite in most states. What is required is that the individual meets the AAAAI practice parameter training standard (trained in anaphylaxis recognition and treatment) and any credential-specific state requirements. Some practices voluntarily pursue formal training documentation through AAAAI or ACAAI programs to demonstrate staff competency as part of their quality assurance program. This voluntary certification may be valuable for accreditation purposes, quality reporting, and staff development — but its absence does not automatically mean non-compliance with administration standards.